MedTrace Logo

Atkins Diet and Prostate Cancer Clinical Trial

NCT00932672 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2015-12-07

No results posted yet for this study

Summary

This study will test the hypothesis that a low-carbohydrate Atkins diet will prevent or at least minimize the metabolic consequences of androgen deprivation therapy (ADT).

Conditions

Interventions

BEHAVIORAL

Atkins Diet

Patients are given an outline of the Atkins diet and are asked to follow it for 6 months

Sponsors & Collaborators

  • VA Greater Los Angeles Healthcare System

    collaborator FED

  • Durham VA Medical Center

    collaborator FED

  • University of California, Los Angeles

    collaborator OTHER

  • Carolina Urologic Research Center

    collaborator OTHER

  • First Urology

    collaborator UNKNOWN

  • Duke University

    lead OTHER

Principal Investigators

  • Stephen J Freedland, MD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00932672 on ClinicalTrials.gov